Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment

Guang Xue He; Yan Guang Xie; Li Xia Wang; Martien W. Borgdorff; Marieke J. van der Werf; Ji Huan Fan; Xing Lu Yan; Fa Bin Li; Xue Zhi Zhang; Yan Lin Zhao; Susan van den Hof

doi:10.1371/journal.pone.0010799

Loading metrics

Open Access

Peer-reviewed

Research Article

Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment

Guang Xue He ,

Contributed equally to this work with: Guang Xue He, Yan Guang Xie

Affiliations National Center for Tuberculosis Control and Prevention, China Center for Disease Control and Prevention (China CDC), Beijing, China, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
⨯
Yan Guang Xie ,

Contributed equally to this work with: Guang Xue He, Yan Guang Xie

Affiliation Heilongjiang Provincial Center for Tuberculosis Control and Prevention, Harbin, Heilongjiang, China
⨯
Li Xia Wang,

Affiliation National Center for Tuberculosis Control and Prevention, China Center for Disease Control and Prevention (China CDC), Beijing, China
⨯
Martien W. Borgdorff,

Affiliation Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
⨯
Marieke J. van der Werf,

Affiliations Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, KNCV Tuberculosis Foundation, The Hague, The Netherlands
⨯
Ji Huan Fan,

Affiliation Public Health School, Peking Union Medical College, Beijing, China
⨯
Xing Lu Yan,

Affiliation Heilongjiang Provincial Center for Tuberculosis Control and Prevention, Harbin, Heilongjiang, China
⨯
Fa Bin Li,

Affiliation Heilongjiang Provincial Center for Tuberculosis Control and Prevention, Harbin, Heilongjiang, China
⨯
Xue Zhi Zhang,

Affiliation Heilongjiang Provincial Center for Tuberculosis Control and Prevention, Harbin, Heilongjiang, China
⨯
Yan Lin Zhao,

Affiliation National Tuberculosis Reference Laboratory, China Center for Disease Control and Prevention (China CDC), Beijing, China
⨯
Susan van den Hof

* E-mail: vandenhofs@kncvtbc.nl

Affiliations Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, KNCV Tuberculosis Foundation, The Hague, The Netherlands
⨯

Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment

Guang Xue He,
Yan Guang Xie,
Li Xia Wang,
Martien W. Borgdorff,
Marieke J. van der Werf,
Ji Huan Fan,
Xing Lu Yan,
Fa Bin Li,
Xue Zhi Zhang,
Yan Lin Zhao

Published: May 24, 2010
https://doi.org/10.1371/journal.pone.0010799

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Multi-drug-resistant tuberculosis
Is the Subject Area "Multi-drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Extensively drug-resistant tuberculosis
Is the Subject Area "Extensively drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Death rates
Is the Subject Area "Death rates" applicable to this article?

Thanks for your feedback.
Sputum
Is the Subject Area "Sputum" applicable to this article?

Thanks for your feedback.
Tuberculosis diagnosis and management
Is the Subject Area "Tuberculosis diagnosis and management" applicable to this article?

Thanks for your feedback.
Mycobacterium tuberculosis
Is the Subject Area "Mycobacterium tuberculosis" applicable to this article?

Thanks for your feedback.